Bausch Health Companies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bausch Health Companies generated cash of $1,032,000,000, which is more than the previous year. Cash used in financing activities reached the amount of $1,475,000,000 last year. Net change in cash is therefore $371,000,000.
Cash Flow
| 2014 | 2.29B | -99.7M | -2.44B |
|---|---|---|---|
| 2015 | 2.20B | -15.57B | 13.62B |
| 2016 | 2.08B | -125M | -1.96B |
| 2017 | 2.29B | 2.88B | -4.96B |
| 2018 | 1.50B | -196M | -1.35B |
| 2019 | 1.50B | -419M | 1.44B |
| 2020 | 1.11B | -261M | -2.29B |
| 2021 | 1.42B | 409M | -1.51B |
| 2022 | -728M | -303M | -474M |
| 2023 | 1.03B | -2.14B | 1.47B |
BHC Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 591M | 2.11B | 1.81B | 3.24B | 723M | 797M | 542M | 597M | 322.6M | 600.3M |
Operating activities | ||||||||||
Net income | -611M | -212M | -937M | -559M | -1.78B | -4.14B | 2.40B | -2.40B | -287.8M | 912.2M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.26B | 1.39B | 1.55B | 1.82B | 2.07B | 2.81B | 2.85B | 2.86B | 2.62B | 1.73B |
Stock-based compensation expense | 132M | 126M | 128M | 105M | 102M | 0 | 87M | 165M | 140.1M | 78.2M |
| Deferred income tax benefit | 132M | 126M | 128M | 105M | 102M | 0 | 87M | 165M | 140.1M | 78.2M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -195M | -57M | -229M | 170M | 39M | 216M | 417M | -34M | -625.9M | -572.4M |
Inventories | -322M | -198M | -16M | -77M | -209M | -5M | 7M | -164M | -276M | -174.3M |
Accounts payable | 158M | -72.02M | 121M | -471M | -149M | -568M | 387M | -144M | 170.3M | 188.6M |
Cash generated by operating activities | 1.03B | -728M | 1.42B | 1.11B | 1.50B | 1.50B | 2.29B | 2.08B | 2.20B | 2.29B |
Investing activities | ||||||||||
Purchases Of Investments | -27M | -17M | -19M | -4M | -16M | -7M | -7M | -1M | -49.3M | -72M |
Investments In Property Plant And Equipment | -215M | -268M | -283M | -309M | -278M | -235M | -336M | -291M | -303.3M | -470.6M |
Acquisitions Net | -1.89B | -45M | -14M | 16M | -180M | 5M | -165M | -49M | -15.45B | -1.10B |
Cash generated by investing activities | -2.14B | -303M | 409M | -261M | -419M | -196M | 2.88B | -125M | -15.57B | -99.7M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 1.89M | 0 | 32.60M | 1.43B | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -24M | -31M | -52M | -30M | -40M | -10M | -4M | -11M | -72M | -44M |
Repayments of term debt | 1.58B | -1.01B | -3.44B | -5.64B | 1.55B | -10.10B | -4.77B | -2.43B | 12.63B | -3.91B |
Cash used in financing activities | 1.47B | -474M | -1.51B | -2.29B | 1.44B | -1.35B | -4.96B | -1.96B | 13.62B | -2.44B |
Net Change In Cash | 371M | -1.52B | 303M | -1.42B | 2.52B | -74M | 255M | -55M | 274.7M | -277.7M |
Cash at end of period | 962M | 591M | 2.11B | 1.81B | 3.24B | 723M | 797M | 542M | 597.3M | 322.6M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |